Alterity Therapeutics Ltd.ASX: ATH

Cleansing Notice Under Section 708A

Sep 7, 2026 at 9:59 PM EDT · Issued by Alterity Therapeutics Ltd. via ASX

Filed with ASX · Sep 7, 2026 at 9:59 PM EDT

On 6ix: 6ix.com/news/cleansing-notice-under-section-708a-1

Alterity Therapeutics Limited ACN 080 699 065 Level 15, 500 Collins Street, Melbourne, Victoria 3000 Australia www.alteritytx.com 8 September 2026 CLEANSING NOTICE UNDER SECTION 708A(5)(E) OF THE CORPORATIONS ACT Alterity Therapeutics Limited (ASX:ATH) (the Company) advises that it has...

View Attachment

6ix hasn’t read this filing yet.

Alterity Therapeutics Ltd. on 6ix

Story so far

Change of Director's Interest Notice - StamlerSep 2, 2026
Change of Director's Interest Notice - MarksSep 2, 2026
Notice of General Meeting/Proxy FormApr 29, 2026

Earlier from Alterity Therapeutics

Application for quotation of securities - ATHSep 7
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026Sep 3
Alterity to Present at Cantor Global Healthcare ConferenceSep 2
Change of Director's Interest Notice - StamlerSep 1
Change of Director's Interest Notice - MarksSep 1

Later from Alterity Therapeutics

Alterity Therapeutics to Present at ASX SMIDcaps ConferenceSep 17
Corporate Presentation September 2026Sep 22
Date of AGM and Closing Date for Director NominationsSep 24
Alterity Presents New Analyses of ATH434 Phase 2 Data in MSAOct 4
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement DisordersOct 5

All Alterity Therapeutics news releases

Follow Alterity Therapeutics into a list and get an email when it puts out news.

Follow Alterity Therapeutics